Back to Trades
Other4
Generate Biomedicines, Inc.
GENB
Total Value
$473.0K
Company Information
- Company Name
- Generate Biomedicines, Inc.
- Ticker Symbol
- GENB
- CIK
- 0002100782
Insider Information
- Name
- Bancel Stephane
- Role
- Insider
- Location
- SOMERVILLE, MA
Filing Details
- Filing Date
- Mar 2, 2026
- Transaction Date
- Feb 26, 2026
- Accession Number
- 0001193125-26-085881
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | 724,160 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Derivative | 29,561 | $16.00 | Grant/Award | $473.0K |
| Mar 2, 2026 | Derivative | 1,100,000 | — | C | — |
Footnotes
- (F1)Each share of Series A Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-1.5190 basis upon the closing of the Issuer's initial public offering on March 2, 2026. The Series A Preferred Stock had no expiration date.
- (F2)Shares held by OCHA LLC, of which the Reporting Person is the controlling unit holder and sole managing member. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- (F3)The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.